Atlas Trials

Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Metastatic Renal Cell Carcinoma

Clinical trial NCT04831138 · TERMINATED

Trial details

NCT number
NCT04831138
Sponsor
University of Texas Southwestern Medical Center
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2021-03-24
Primary completion
2023-04-04
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.